220127-57-1
MOSINTER
220127-57-1
Availability: | |
---|---|
Payment & Shipping Terms | Supply Capacity | ||
Payment Terms: | T/T, WU | Production Capacity: | 1000kg/year |
Min. Order: | 1 Gram | Packing: | according to the customer's requirements |
Means of Transport: | Ocean, Air, Land | Delivery Date: | 7 days |
Imatinib mesylate
CAS 220127-57-1
Imatinib mesylate can inhibit BCR ABL tyrosine kinase in vitro and in vivo, selectively inhibit the proliferation and induce apoptosis of BCR ABL positive cell lines, chronic myeloid leukemia and fresh cells from patients with acute lymphoblastic leukemia. In addition, imatinib mesylate can also inhibit the tyrosine kinase of PDGF receptor, SCF and c-kit receptor, thus inhibiting the cell behavior mediated by PDGF and stem cell factor.
We can customize according to customer's requirement
if you have any question pls mail us or call us.